PTEN and neoplasm: These results also raise the question of whether there are other molecular abnormalities that are mutually exclusive of ERG/ETV1 gene rearrangements that may contribute to the worse outcome of patients with non-ERG/ETV1 gene rearranged/PTEN loss tumours.